Oxford Asset Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Oxford Asset Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-256,800	Closed	-$44.4M	–	825
2015 Q1	$44.4M	Buy	256,800 +252,071	+5,330%	+$37M	1.13%	16
2014 Q4	$548K	Buy	+4,729	New	+$573K	0.01%	557
2014 Q3	–	Sell	-32,399	Closed	-$3.98M	–	844
2014 Q2	$3.98M	Buy	32,399 +23,037	+246%	+$2.55M	0.13%	218
2014 Q1	$970K	Sell	9,362 -65,687	-88%	-$6.73M	0.03%	459
2013 Q4	$6.75M	Buy	75,049 +48,371	+181%	+$3.86M	0.17%	176
2013 Q3	$1.78M	Sell	26,678 -69,009	-72%	-$4.76M	0.04%	490
2013 Q2	$6.33M	Buy	+95,687	New	+$5.47M	0.17%	177

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Oxford Asset Management's SLXP Position: Q2 2015 in Review

Oxford Asset Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 256,800 shares — an estimated $44.4M sold.

Oxford Asset Management first reported a position in SLXP in Q2 2013 and held it in 7 quarters. The position peaked at $44.4M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Oxford Asset Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Oxford Asset Management sold 256,800 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $44.4M.
Oxford Asset Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 7 quarters.
Oxford Asset Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $44.4M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Oxford Asset Management's 13F filing for Q2 2015, filed 11 Aug 2015.